SEC Filings

Form S-3/A
ZOMEDICA PHARMACEUTICALS CORP. filed this Form S-3/A on 01/18/2019
Document Outline
Entire Document (330.2 KB)
Subdocument 1 - S-3/A - FORM S-3/A
Page 1 - As filed with the Securities and Exchange Commission on January 18, 2019
Page 2 - CALCULATION OF REGISTRATION FEE
Page 3 - his Registration Statement shall hereafter become effective in accordance with the provisions of Sec
Page 4 - The information in this prospectus is not complete and may be changed. The selling shareholders name
Page 5 - TABLE OF CONTENTS
Page 6 - ABOUT THIS PROSPECTUS
Page 7 - PROSPECTUS SUMMARY
Page 8 - N/A
Page 9 - Implications of Being an Emerging Growth Company
Page 10 - The Offering
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - Relationships with Selling Shareholders
Page 15 - Dividend Rights
Page 16 - Action Necessary to Change the Rights of Holders of our Shares
Page 17 - Shareholder Meetings
Page 18 - Transfer Agent and Registrar
Page 19 - N/A
Page 20 - The following summary is not a substitute for careful tax planning and advice. U.S. Holders of commo
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - General Rules Applicable to the Ownership and Disposition of Common Shares
Page 25 - Additional Considerations
Page 26 - N/A
Page 27 - CERTAIN CANADIAN INCOME TAX CONSIDERATIONS
Page 28 - PLAN OF DISTRIBUTION
Page 29 - N/A
Page 30 - LEGAL MATTERS
Page 31 - Up to 84,747,162 Common Shares
Page 32 - Item 15. Indemnification of Directors and Officers.
Page 33 - Item 16. Exhibits.
Page 34 - N/A
Page 35 - SIGNATURES
Page 36 - EXHIBIT INDEX
Subdocument 2 - EX-5.1 - EXHIBIT 5.1
Page 1 - N/A
Subdocument 3 - EX-23.1 - EXHIBIT 23.1
Page 1 - N/A